Experience

Health Data Research UK (HDR UK)

• United Kingdom
• Research Services
• 1 - 100 Employee

• Strategy Advisor

  • Feb 2023 - Present



PLOS

• United States
• Book and Periodical Publishing
• 300 - 400 Employee

• Associate Editor

  • Nov 2022 - Feb 2023

  Associate Editor in the Public Health and Medicine Team at PLOS ONE Associate Editor in the Public Health and Medicine Team at PLOS ONE



University of Bristol

• United Kingdom
• Higher Education
• 700 & Above Employee

• Senior Research Associate in Applied Genetic Epidemiology

  • Mar 2019 - Nov 2022

  • Triangulating results from observational and genetic epidemiological analyses to examine the impact of metabolic disease on the circulating metabolome and subsequent cancer risk. • Responsible for planning and conducting prospective observational and Mendelian randomization studies, genome wide association studies, recall by genotype experiments, and writing manuscripts for publication. • Augmenting randomized control trials with the collection and analysis of metabolomics samples, to capture the underlying biological mechanisms of intervention effects. • Facilitating cross-disciplinary collaborations between a pre-clinical and population health research teams.• Grant writing and development.• Supervision of PhD, MSc and BSc students. Show less

• Research Associate in Genetic Epidemiology and Cancer Cell Biology

  • Nov 2017 - Mar 2019

  • Examined associations of Type 2 diabetes phenotypes with colorectal cancer risk.• Responsible for maintaining laboratory equipment and conducting experimental studies based on a preclinical model of colorectal cancer progression. • Responsible for identifying laboratory work that could be complemented with observational or Mendelian randomization study designs (or vice-versa) and writing manuscripts for publication.• Supervised MSc and BSc students conducting wet lab and epidemiology research projects. Show less

• Wellcome Trust PhD Researcher

  • Oct 2013 - Nov 2017

  I undertook my doctoral studies at the MRC Integrative Epidemiology Unit, University of Bristol. My PhD research focused on the effect of LDL-lowering therapy on prostate cancer risk and progression using epidemiological and preclinical techniques, supervised by Prof. Richard Martin, Dr. Claire Perks and Prof. Jeffery Holly.